SAR288 has emerged as a novel therapeutic target for COVID-19. This pharmaceutical agent exhibits remarkable antiviral activity against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have https://prestonkgsd427457.activoblog.com/46130332/a-breakthrough-in-covid-19-therapy